122 related articles for article (PubMed ID: 19596263)
21. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
[TBL] [Abstract][Full Text] [Related]
22. Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism.
Rodríguez C; Sobrino T; Agulla J; Bobo-Jiménez V; Ramos-Araque ME; Duarte JJ; Gómez-Sánchez JC; Bolaños JP; Castillo J; Almeida Á
Cell Death Differ; 2017 Jan; 24(1):144-154. PubMed ID: 27768124
[TBL] [Abstract][Full Text] [Related]
23. TP53 codon 72 polymorphism and breast cancer in northern Iran.
Kazemi M; Salehi Z; Chakosari RJ
Oncol Res; 2009; 18(1):25-30. PubMed ID: 19911701
[TBL] [Abstract][Full Text] [Related]
24. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
25. TP53 codon 72 polymorphism in 12 populations of insular Southeast Asia and Oceania.
Kashima T; Makino K; Soemantri A; Ishida T
J Hum Genet; 2007; 52(8):694-697. PubMed ID: 17607506
[TBL] [Abstract][Full Text] [Related]
26. The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism.
Ramos-Araque ME; Rodriguez C; Vecino R; Cortijo Garcia E; de Lera Alfonso M; Sanchez Barba M; Colàs-Campàs L; Purroy F; Arenillas JF; Almeida A; Delgado-Esteban M
Transl Stroke Res; 2019 Apr; 10(2):204-215. PubMed ID: 29687302
[TBL] [Abstract][Full Text] [Related]
27. [Association of gene TP53 polymorphic marker Pro72Arg with clinical characteristics of chronic glomerulonephritis].
Kamyshova ES; Shvetsov MIu; Shestakov AE; Kutyrina IM; Nosikov VV
Ter Arkh; 2011; 83(6):27-32. PubMed ID: 21786572
[TBL] [Abstract][Full Text] [Related]
28. The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing.
Testa R; Bonfigli AR; Salvioli S; Invidia L; Pierini M; Sirolla C; Marra M; Testa I; Fazioli F; Recchioni R; Marcheselli F; Olivieri F; Lanari L; Franceschi C
Mech Ageing Dev; 2009 Aug; 130(8):497-500. PubMed ID: 19523975
[TBL] [Abstract][Full Text] [Related]
29. Low rates of somatic p53 mutations in keratoacanthomas.
Suk JD; Park WS; Kim DK
J Dermatol Sci; 2009 Jan; 53(1):72-3. PubMed ID: 18829268
[No Abstract] [Full Text] [Related]
30. The Pro/Pro genotype at TP53 codon 72 polymorphism is associated with early onset glioblastoma.
El Hallani S; Rossetto M; Sanson M
Cancer Genet; 2012 Dec; 205(12):677. PubMed ID: 23228226
[No Abstract] [Full Text] [Related]
31. Influence of the TP53 codon 72 polymorphism on the cellular responses to X-irradiation in fibroblasts from nonagenarians.
den Reijer PM; Maier AB; Westendorp RG; van Heemst D
Mech Ageing Dev; 2008 Apr; 129(4):175-82. PubMed ID: 18272203
[TBL] [Abstract][Full Text] [Related]
32. The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype.
Hebert-Magee S; Yu H; Behring M; Jadhav T; Shanmugam C; Frost A; Eltoum IE; Varambally S; Manne U
PLoS One; 2019; 14(2):e0211734. PubMed ID: 30730944
[TBL] [Abstract][Full Text] [Related]
33. Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):261-2. PubMed ID: 19760041
[No Abstract] [Full Text] [Related]
34. Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.
Wrench D; Waters R; Carlotti E; Iqbal S; Matthews J; Calaminici M; Gribben J; Lister TA; Fitzgibbon J
Haematologica; 2009 Jan; 94(1):148-50. PubMed ID: 19029147
[No Abstract] [Full Text] [Related]
35. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
36. Arg72Pro p53 polymorphism in Italian women: no association with endometriosis.
Vietri MT; Molinari AM; Iannella I; Cioffi M; Bontempo P; Ardovino M; Scaffa C; Colacurci N; Cobellis L
Fertil Steril; 2007 Nov; 88(5):1468-9. PubMed ID: 17412337
[TBL] [Abstract][Full Text] [Related]
37. Is a TNF alpha polymorphism responsible for mutations in the TP53 gene?
Berglund M; Zainuddin N; Thunberg U; Enblad G
Scand J Immunol; 2011 Feb; 73(2):154-5. PubMed ID: 21198757
[No Abstract] [Full Text] [Related]
38. T>C transition in codon 72 (TCG-->CCG), S72P, a putative hotspot in PMP22.
Ekici AB; Park O; Korinthenberg R; Grehl H; Rautenstrauss B
Hum Mutat; 2001; 17(1):81. PubMed ID: 11139264
[No Abstract] [Full Text] [Related]
39. The P561T polymorphism of the growth hormone receptor gene has an inhibitory effect on mandibular growth in young children.
Sasaki Y; Satoh K; Hayasaki H; Fukumoto S; Fujiwara T; Nonaka K
Eur J Orthod; 2009 Oct; 31(5):536-41. PubMed ID: 19447840
[TBL] [Abstract][Full Text] [Related]
40. TP53 gene polymorphism: importance to cancer, ethnicity and birth weight in a Brazilian cohort.
Thurow HS; Haack R; Hartwig FP; Oliveira IO; Dellagostin OA; Gigante DP; Horta BL; Collares T; Seixas FK
J Biosci; 2011 Dec; 36(5):823-31. PubMed ID: 22116280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
